Notably, experimental models of diabetes revealed that blocking C3a/C3aR or C5a/C5aR signaling reduced tubulointerstitial fibrosis and alleviated inflammation of the injured kidney [10, 11]. This evidence concerns the gene C5AR1 and diabetes mellitus.